Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

14-3-3ζ silencing retards tongue squamous cell carcinoma progression by inhibiting cell survival and migration

Abstract

Our study aimed to investigate the isoform-specific distribution of 14-3-3 in tongue squamous cell carcinoma (TSCC) and their association with cancer progression, and to further discuss their roles in cancer cell survival. In this study, 42 TSCC specimens and their matched normal para-carcinoma sections were collected. The immunohistochemistry analysis identified that 14-3-3σ and ζ isoforms presented significantly higher expression in cancerous tissues compared with the matched normal tongue tissue sections. 14-3-3ζ expression was associated with tumor T stage, lymph node metastasis and poor prognosis of TSCC. In vitro study revealed that 14-3-3ζ silencing alleviated the proliferation and migration of TSCC cells while promoted cancer cell apoptosis. 14-3-3ζ could bind to and inactivate FOXO3a transcription factor, in turn leading to the movement of the 14-3-3ζ–FOXO3a complex from nucleus to cytoplasm, which was inhibited after 14-3-3ζ silencing. Both 14-3-3ζ and FOXO3a silencing increased caspase 3 and 9 activation, while reduced inner mitochondrial membrane potential. Collectively, 14-3-3ζ may serve as a hallmark and prognostic marker of TSCC. 14-3-3ζ can bind to the FOXO3a transcription factor to promote the export of the complex to the cytoplasm, leading to enhanced proliferation and migration of tongue cancer cells.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Korpi JT, Kervinen V, Mäklin H, Väänänen A, Lahtinen M, Läärä E et al. Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer. Brit J Cancer 2008; 98: 766–775.

    Article  CAS  Google Scholar 

  2. Song X, Zhang W, Zhang Y, Zhang H, Fu Z, Ye J et al. Expression of semaphorin 3A and neuropilin 1 with clinicopathological features and survival in human tongue cancer. Med Oral Patol Oral Cir Bucal 2012; 17: e962.

    Article  Google Scholar 

  3. Chang C-C, Yang Y-J, Li Y-J, Chen S-T, Lin B-R, Wu T-S et al. MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma. Oral Oncol 2013; 49: 923–931.

    Article  CAS  Google Scholar 

  4. Mhawech P . 14-3-3 proteins—an update. Cell Res 2005; 15: 228–236.

    Article  CAS  Google Scholar 

  5. Freeman AK, Morrison DK . 14-3-3 Proteins: diverse functions in cell proliferation and cancer progression. Semin Cell Dev Biol 2011; 22: 681–687.

    Article  CAS  Google Scholar 

  6. Fu H, Subramanian RR, Masters SC . 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 2000; 40: 617–647.

    Article  CAS  Google Scholar 

  7. Matta A, Bahadur S, Duggal R, Gupta SD, Ralhan R . Over-expression of 14-3-3zeta is an early event in oral cancer. BMC Cancer 2007; 7: 169.

    Article  Google Scholar 

  8. Matta A, Siu KM, Ralhan R . 14-3-3 zeta as novel molecular target for cancer therapy. Exp Opin Therap Target 2012; 16: 515–523.

    Article  CAS  Google Scholar 

  9. Laimer K, Blassnig N, Spizzo G, Kloss F, Rasse M, Obrist P et al. Prognostic significance of 14-3-3sigma expression in oral squamous cell carcinoma (OSCC). Oral Oncol 2009; 45: 127–134.

    Article  CAS  Google Scholar 

  10. Horie M, Suzuki M, Takahashi E-i, Tanigami A . Cloning, expression, and chromosomal mapping of the human 14-3-3 γ gene (YWHAG) to 7q11. 23. Genomic 1999; 60: 241–243.

    Article  CAS  Google Scholar 

  11. Qi W, Liu X, Qiao D, Martinez JD . Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer 2005; 113: 359–363.

    Article  CAS  Google Scholar 

  12. Hayashi E, Kuramitsu Y, Fujimoto M, Zhang X, Tanaka T, Uchida K et al. Proteomic profiling of differential display analysis for human oral squamous cell carcinoma: 14-3-3 σ Protein is upregulated in human oral squamous cell carcinoma and dependent on the differentiation level. Proteomics Clin Appli 2009; 3: 1338–1347.

    Article  CAS  Google Scholar 

  13. Rodriguez LG, Guan JL . 14-3-3 regulation of cell spreading and migration requires a functional amphipathic groove. J Cell Physiol 2005; 202: 285–294.

    Article  CAS  Google Scholar 

  14. Liu MY, Cai S, Espejo A, Bedford MT, Walker CL . 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site (s). Cancer Res 2002; 62: 6475–6480.

    CAS  PubMed  Google Scholar 

  15. Nomura M, Shimizu S, Sugiyama T, Narita M, Ito T, Matsuda H et al. 14-3-3 Interacts directly with and negatively regulates pro-apoptotic Bax. J Biol Chem 2003; 278: 2058–2065.

    Article  CAS  Google Scholar 

  16. Samuel T, Weber HO, Rauch P, Verdoodt B, Eppel J-T, McShea A et al. The G2/M regulator 14-3-3σ prevents apoptosis through sequestration of Bax. J Biol Chem 2001; 276: 45201–45206.

    Article  CAS  Google Scholar 

  17. Wang H, Zhang Z, Li R, Ang KK, Zhang H, Caraway NP et al. Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer. Int J Cancer 2005; 116: 285–290.

    Article  CAS  Google Scholar 

  18. Baljinnyam E, Umemura M, De Lorenzo MS, Xie LH, Nowycky M, Iwatsubo M et al. Gbetagamma subunits inhibit Epac-induced melanoma cell migration. BMC Cancer 2011; 11: 256.

    Article  CAS  Google Scholar 

  19. Tzivion G, Dobson M, Ramakrishnan G . FoxO transcription factors; regulation by AKT and 14-3-3 proteins. Biochim Biophys Acta 2011; 1813: 1938–1945.

    Article  CAS  Google Scholar 

  20. Obsilova V, Silhan J, Boura E, Teisinger J, Obsil T . 14-3-3 proteins: a family of versatile molecular regulators. Physiol Res 2008; 57 (Suppl 3): S11–S21.

    CAS  Google Scholar 

  21. Ralhan R, Masui O, DeSouza LV, Matta A, Macha M, Siu K . Identification of proteins secreted by head and neck cancer cell lines using LC‐MS/ MS: strategy for discovery of candidate serological biomarkers. Proteomics 2011; 11: 2363–2376.

    Article  CAS  Google Scholar 

  22. Zhao GY, Ding JY, Gu J, Lu CL, Lin ZW, Guo J et al. The overexpression of 14-3-3ζ and Hsp27 promotes non–small cell lung cancer progression. Cancer 2014; 120: 652–663.

    Article  CAS  Google Scholar 

  23. Hatzipetros I, Gocze P, Koszegi T, Jaray A, Szereday L, Polgar B et al. Investigating the clinical potential for 14-3-3 zeta protein to serve as a biomarker for epithelial ovarian cancer. J Ovarian Res 2013; 6: 79.

    Article  Google Scholar 

  24. Fu Z, Tindall DJ . FOXOs, cancer and regulation of apoptosis. Oncogene 2008; 27: 2312–2319.

    Article  CAS  Google Scholar 

  25. Arden KC . Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer. Exp Gerontol 2006; 41: 709–717.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to X H Han.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on Cancer Gene Therapy website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jin, L., Han, X., Jie, Y. et al. 14-3-3ζ silencing retards tongue squamous cell carcinoma progression by inhibiting cell survival and migration. Cancer Gene Ther 23, 206–213 (2016). https://doi.org/10.1038/cgt.2016.15

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2016.15

This article is cited by

Search

Quick links